February 28, 2015 1:17 PM ET


Company Overview of Astex Pharmaceuticals, Inc.

Executive Profile

David J. Bearss Ph.D.

Founder and Chief Executive Officer , Tolero Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 3 different industries.

See Board Relationships


Dr. David J. Bearss, Ph.D. is the Founded Tolero Pharmaceuticals, Inc. in 2011 and serves as its Chief Executive Officer. Dr. Bearss has been Biology Consultant at SuperGen Inc. (AKA Astex Pharmaceuticals, Inc.) since September 2009. Dr. Bearss served as Chief Scientific Officer of SuperGen Inc. from November 2008 to September 2009 and served as its Vice President from April 2006 to September 2009. Dr. Bearss served as Chief Scientist of SuperGen Inc. and oversaw the ...

Corporate Headquarters

4140 Dublin Boulevard
Dublin, California 94568

United States

Phone: 925-560-0100
Fax: 925-560-0101

Board Members Memberships

There is no Board Members Memberships data available.


University of Texas Health Science Center - San Antonio
Brigham Young University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Astex Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.